| 000 | 02759 a2200661 4500 | ||
|---|---|---|---|
| 005 | 20250513032631.0 | ||
| 264 | 0 | _c19951121 | |
| 008 | 199511s 0 0 eng d | ||
| 022 | _a0037-9727 | ||
| 024 | 7 |
_a10.3181/00379727-210-43936 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOliver, B L | |
| 245 | 0 | 0 |
_aTransforming growth factor-alpha and epidermal growth factor activate mitogen-activated protein kinase and its substrates in intestinal epithelial cells. _h[electronic resource] |
| 260 |
_bProceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) _cNov 1995 |
||
| 300 |
_a162-70 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlotting, Northern |
| 650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aCatechols _xpharmacology |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDNA _xbiosynthesis |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aEpidermal Growth Factor _xpharmacology |
| 650 | 0 | 4 | _aEpithelial Cells |
| 650 | 0 | 4 |
_aEpithelium _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression _xdrug effects |
| 650 | 0 | 4 |
_aGenes, fos _xdrug effects |
| 650 | 0 | 4 |
_aGenes, jun _xdrug effects |
| 650 | 0 | 4 |
_aGenes, myc _xdrug effects |
| 650 | 0 | 4 | _aGenistein |
| 650 | 0 | 4 |
_aIntestinal Mucosa _xcytology |
| 650 | 0 | 4 |
_aIntestine, Small _xmetabolism |
| 650 | 0 | 4 |
_aIsoflavones _xpharmacology |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMitogen-Activated Protein Kinase 1 |
| 650 | 0 | 4 | _aMitogen-Activated Protein Kinase 3 |
| 650 | 0 | 4 | _aMitogen-Activated Protein Kinases |
| 650 | 0 | 4 |
_aMyelin Basic Protein _xmetabolism |
| 650 | 0 | 4 |
_aNitriles _xpharmacology |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-fos _xbiosynthesis |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-jun _xbiosynthesis |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-myc _xbiosynthesis |
| 650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 |
_aThymidine _xmetabolism |
| 650 | 0 | 4 |
_aTransforming Growth Factor alpha _xpharmacology |
| 650 | 0 | 4 | _aTyrphostins |
| 700 | 1 | _aSha'afi, R I | |
| 700 | 1 | _aHajjar, J J | |
| 773 | 0 |
_tProceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) _gvol. 210 _gno. 2 _gp. 162-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3181/00379727-210-43936 _zAvailable from publisher's website |
| 999 |
_c7567744 _d7567744 |
||